{"schema_version":"secwatch.filing_event.v1","accession":"0001356576-25-000006","form_type":"8-K","ticker":"SUPN","cik":"0001356576","company_name":"SUPERNUS PHARMACEUTICALS, INC.","filed_at":"2025-02-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.420061+00:00","generated_at":"2026-05-26T23:17:45.100516+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Supernus schedules Q4 and full year 2024 earnings release and call for Feb 25, 2025","bullets":["Earnings release expected after market close on Tuesday, February 25, 2025.","Conference call at 4:30 pm ET hosted by CEO Jack Khattar and CFO Tim Dec.","Live webcast accessible on Supernus Investor Relations website; replay for 60 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001356576-25-000006","json":"https://secwatch.observer/filing/0001356576-25-000006.json","markdown":"https://secwatch.observer/filing/0001356576-25-000006.md","text":"https://secwatch.observer/filing/0001356576-25-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1356576/000135657625000006/0001356576-25-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1356576/000135657625000006/supn-20250211.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T23:17:45.100516+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}